Shape Therapeutics
shapetx.com
Shape Therapeutics develops RNA editing-based gene therapies and adeno-associated virus (AAV) delivery technologies for neurological and genetic diseases. Its mission is to advance treatments using AI-designed RNA editing platforms.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Gene therapy, RNA therapeutics, AAV delivery, Life sciences
- Founded
- 2018 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Shape Therapeutics Inc Seattle business license
Is this your organization? Claim it
Executives
-
David Huss Executive, Chief Scientific Officer and Interim CEO
Former founders
-
Francois Vigneault Former founder
